Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Addus HomeCare Corp. (NASDAQ: ADUS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the information. Addus HomeCare is a Delaware corporation based in Frisco, Texas that provides personal care, hospice and home health services, and its filings offer detailed insight into this business.
Investors can use this page to access periodic and current reports where the company discusses its operations, financial condition and governance. Form 8-K filings, for example, are used by Addus HomeCare to report events such as quarterly earnings announcements, annual meeting voting results and acquisition-related updates. Recent 8-K and 8-K/A filings describe the company’s results of operations for specific quarters, the completion and financial reporting of the Gentiva personal care acquisition and the outcomes of its 2025 annual meeting of stockholders.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available through EDGAR) typically contain segment information for personal care, hospice and home health, along with discussions of payor mix, reimbursement exposure and risk factors. For a home health care services company like Addus HomeCare, these filings are central to understanding how government programs, managed care organizations and other payors affect revenue.
On Stock Titan, AI-generated summaries are designed to highlight key points from lengthy filings, such as changes in segment performance, updates on acquisitions, or governance decisions disclosed in proxy-related materials. Users can also review exhibits referenced in 8-K filings, including earnings press releases that are incorporated by reference. This page further facilitates monitoring of executive and director matters disclosed in meeting results and other governance-related filings.
By combining real-time EDGAR updates with AI explanations, the Addus HomeCare SEC filings page helps readers navigate complex regulatory documents, from 10-K and 10-Q reports to 8-K and 8-K/A filings, and understand how these disclosures relate to the company’s home-based care operations.
Addus HomeCare Corporation reports strong expansion as a multi-segment home care provider focused on personal care, hospice and home health services. For the year ended December 31, 2025, total net service revenue rose to $1,422,530,000 from $1,154,599,000, while net income increased to $95,910,000 from $73,598,000.
The company served about 107,000 consumers across 23 states through roughly 262 offices, with a model centered on mostly dual-eligible Medicare/Medicaid patients and growing relationships with managed care organizations. Growth comes from both organic initiatives and acquisitions; six deals completed in 2024–2025 added meaningful revenue. Addus highlights opportunities from aging demographics, home- and community-based services demand and industry consolidation, while also warning about significant regulatory, Medicaid funding, labor cost and macroeconomic risks that could pressure margins and growth.
Addus HomeCare Corp executive Monica Raines reported both a stock award and a small sale of shares. On
On
Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale. On February 20, he acquired 2,858 shares of common stock as a grant, at no cost, which vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and potential acceleration upon a change in control. On February 23, he sold 561 shares at
Addus HomeCare Corp EVP and Chief Development Officer Cliff Donald Blessing reported mixed share activity. He sold 371 shares of common stock in an open-market transaction at
Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale. On February 20, 2026, he acquired 3,117 shares of common stock as a grant with no purchase price, lifting his holdings to 10,913 shares.
The granted shares vest in three equal installments on each of February 20, 2027, 2028, and 2029, subject to continued service and change-in-control provisions. On February 23, 2026, he sold 577 shares at $114.91 per share in an open-market trade under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 10,336 directly owned shares.
Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale. On February 20, 2026, he acquired 3,429 shares of common stock as a grant or award at no cost. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and customary change-in-control provisions.
On February 23, 2026, Tucker executed an open-market sale of 658 shares of common stock at $114.91 per share. According to the footnote, this sale was made under a previously established Rule 10b5-1 trading plan adopted on March 13, 2025 and was intended to satisfy tax obligations arising from the vesting of restricted stock awards.
Addus HomeCare Corp executive Darby Anderson reported mixed share activity. On
On
Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions. He received a grant of 3,897 common shares at no cost, vesting in three equal installments on February 20 of 2027, 2028, and 2029. He then executed an open-market sale of 737 shares at $114.91 under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 21,339 directly held shares.
Addus HomeCare Corp Executive Vice President and Chief Financial Officer Brian Poff reported two stock transactions. On February 20, 2026, he acquired 11,431 shares of common stock as a grant that will vest in three equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions.
On February 23, 2026, he sold 1,858 shares of common stock at $114.91 per share in an open-market transaction pursuant to a previously established Rule 10b5-1 trading plan, to cover tax obligations from restricted stock vesting. After the sale, he directly owned 66,553 shares of Addus common stock.
Addus HomeCare Corp reported that President and Chief Operating Officer Heather Brianne Dixon acquired a grant of 12,470 shares of common stock at no cost as equity compensation. These shares vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions. Following this grant, she directly holds a total of 44,659 common shares.